Long-term survival rates double previous estimates for locally advanced lung cancer
Long-term results of a phase III clinical trial indicate that survival rates for patients receiving chemoradiation for unresectable, locally advanced non-small cell lung cancer (NSCLC) may be more than twice as high as previous ...
Sep 25, 2017